Concomitant Treatment With Lumasiran and Nedosiran in a Child With Primary Hyperoxaluria Type 1
Saved in:
| Main Authors: | Eline Braekman, Ann Raes, Ruth De Bruyne, Patrick Verloo, Agnieszka Prytula |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924034156 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PHYOX3: Nedosiran Long-Term Safety and Efficacy in Patients With Primary Hyperoxaluria Type 1
by: John C. Lieske, et al.
Published: (2025-06-01) -
Multicenter Long-Term Real World Data on Treatment With Lumasiran in Patients With Primary Hyperoxaluria Type 1
by: Cristina Martin-Higueras, et al.
Published: (2024-01-01) -
Recovery From Severe Heart Failure in a Patient With Primary Hyperoxaluria Type 1 After Treatment With Lumasiran, Pyridoxine, and Kidney Transplant
by: Mira Choi, et al.
Published: (2024-06-01) -
Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1: Results from a Phase III Clinical Trial
by: Jeffrey M. Saland, et al.
Published: (2024-07-01) -
WCN25-902 LUMASIRAN EFFICACY AND KIDNEY OUTCOME IN CHILDREN WITH PRIMARY HYPEROXALURIA TYPE 1: SINGLE-CENTER EXPERIENCE
by: Larisa Prikhodina, et al.
Published: (2025-02-01)